본문 바로가기
KERD
논문KCI 등재

약물유해반응 보고에 대한 개국약국 약사들의 태도 및 지식에 관한 연구

Attitude and Knowledge of Community Pharmacists to Adverse Drug Reaction Reporting

1

조회

0

다운로드

8

인용

0

참고문헌

키워드

주제분류약학

초록

The purpose of this study was to evaluate the attitude and knowledge of community pharmacists to spontaneous adverse drug reaction (ADR) reporting. A survey was conducted in 103 community pharmacists in Seoul and Kyung-Gi Province from September to October, 2009. Almost half (53, 51.5%) and three-fourths (79, 76.7%) of respondents knew they could participate in ADR reporting in the Regional Pharmacovigilance Center (RPC) or Korean Food and Drug Administration (KFDA). However, only three of them have reported an ADR to the RPC and none of them have reported to KFDA. A majority of the respondents (96, 93.2%) felt that ADR reporting was a professional obligation for pharmacists. The purpose of an ADR reporting was incorrectly identified by most pharmacists. ADR reporting was encouraged if the reaction was serious and a new product. The most frequently mentioned barriers to reporting were: uncertainty concerning the causal relationship (86.3%) and not knowing how to report an ADR (83.2%). Only 19 (18.4 %) respondents had received education on how to report ADR. Education was the most recognized method of improving ADR reporting. This study showed the knowledge of ADR reporting among community pharmacists is inadequate. Education and training should be reinforced in order to improve ADR reporting by community pharmacists.

Abstract

The purpose of this study was to evaluate the attitude and knowledge of community pharmacists to spontaneous adverse drug reaction (ADR) reporting. A survey was conducted in 103 community pharmacists in Seoul and Kyung-Gi Province from September to October, 2009. Almost half (53, 51.5%) and three-fourths (79, 76.7%) of respondents knew they could participate in ADR reporting in the Regional Pharmacovigilance Center (RPC) or Korean Food and Drug Administration (KFDA). However, only three of them have reported an ADR to the RPC and none of them have reported to KFDA. A majority of the respondents (96, 93.2%) felt that ADR reporting was a professional obligation for pharmacists. The purpose of an ADR reporting was incorrectly identified by most pharmacists. ADR reporting was encouraged if the reaction was serious and a new product. The most frequently mentioned barriers to reporting were: uncertainty concerning the causal relationship (86.3%) and not knowing how to report an ADR (83.2%). Only 19 (18.4 %) respondents had received education on how to report ADR. Education was the most recognized method of improving ADR reporting. This study showed the knowledge of ADR reporting among community pharmacists is inadequate. Education and training should be reinforced in order to improve ADR reporting by community pharmacists.

참고문헌 (20)

  1. International Drug Monitoring: The role of the Hospital, "World Health Organization", World Health Organization, ~, pp.Technical Report Series No. 425 (1966)
  2. Bennett CL, "Evaluation of serious adverse drug reaction", Arch Intern Med, 167, pp.1041~1149 (2007)
  3. Moore TJ, "Serious adverse events reported to the Food and Drug Administration, 1995-2005", Arch Intern Med, 167, pp.1752~1759 (2007)
  4. Johnson JA, "Drug-related morbidity and mortality: A cost-of-illness model", Arch Intern Med, 155, pp.1949~1956 (1995)
  5. "통계청 Website"[URL]
  6. "식품의약품안전청 Website"[URL]
  7. 최남경, "우리나라 약물유해반응 감시체계", 예방의학회지, 40(4), pp.278~284 (2007), 대한예방의학회
  8. Green FG, "Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting", Br J Clin Pharmcol, 51, pp.81~86 (2001)
  9. Oshikoya KA, "Perception of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria", BMC Clinical Pharmacology, 9, pp.14~21 (2009)
  10. Herdeiro MT, "Physician’s attitudes and adverse drug reaction reporting. A case-control study in Portugal", Drug Safety, 28, pp.825~833 (2005)
  11. Gootheest AC van, "Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting", Int J Pharm Pract, 10, pp.267~272 (2002)
  12. Green CF, "Community pharmaicsts’ attitude to adverse drug reaction reporting", Int J Pharm Pract, 7, pp.92~99 (1999)
  13. American Society of Health-System Pharmacists, "ASHP guidelines on adverse drug reaction monitoring and reporting", Am J Health-Syst Pharm, 52, pp.417~419 (1995)
  14. The Learning Center, "Pharmacists are number one. Continuing pharmacy education" (1999), University of British Columbia
  15. Gootheest AC van, "Contribution of pharmacists to the reporting of adverse drug reactions", Pharmacoepidemiol Drug Saf, 11, pp.205~210 (2002)
  16. Scott HD, "Physician reporting of adverse reactions: results of the Rhode Island adverse drug reaction reporting project", JAMA, 263, pp.1785~1788 (1990)
  17. Figuerias A, "An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial", JAMA, 296, pp.1086~1093 (2006)
  18. Kelly M, "Factors influencing adverse drug reaction reporting in New South Wlaes teaching hospitals", Drug Saf, 22, pp.161~168 (2004)
  19. Sweis D, "A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain", Drug Saf, 23, pp.165~178 (2000)
  20. Institude of Medicine report: To error is human: building a safer health system, "Kohen LT", National Academy of Sciences, ~ (1999)

관련 논문AI추천

이 간행물의 다른 논문 (11건)